Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-27 @ 12:26 AM
Study NCT ID:
NCT00935792
Status:
COMPLETED
Last Update Posted:
2017-09-26
First Post:
2009-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-06
First Submit QC Date:
None
Study First Post Date:
2009-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-29
Results First Submit QC Date:
None
Results First Post Date:
2016-12-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-28
Last Update Post Date:
2017-09-26
Last Update Post Date Type:
ACTUAL